According to Gram Research analysis, a five-plant herbal supplement called Vernolac showed promise in slowing cancer cell growth in laboratory tests, affecting cancer cells at concentrations of 42-85 micrograms per milliliter while having minimal effect on healthy cells. However, this is early-stage research conducted only in computer models and lab dishes—no human trials have been completed, and the supplement should not be used as a cancer treatment without extensive additional testing and medical supervision.
Researchers studied Vernolac, a supplement made from five different plants, to see if it could help fight cancer. Using computer models and lab tests, they found that chemicals in the blend may slow cancer cell growth in multiple ways. The study showed the supplement was selective—it slowed cancer cells more than healthy cells. While these early results are promising, this research is still in the lab stage and hasn’t been tested in people yet. Scientists say it could potentially work alongside regular cancer treatments, but much more testing is needed before anyone should use it as a cancer treatment.
Key Statistics
A 2026 research article published in PLOS ONE found that Vernolac extract reduced the growth of brain cancer cells (NTERA-2) at an IC50 of 42.41 micrograms per milliliter while having minimal effect on healthy breast cells at 803.5 micrograms per milliliter, suggesting selective targeting of cancer over normal cells.
Network pharmacology analysis of Vernolac identified 155 drug-like phytochemicals from five plants that interact with 137 cancer-related protein targets, with 14 key hub proteins including AKT1, BCL2, and STAT3 involved in cell growth, death, and immune response pathways.
Computer modeling and molecular docking studies revealed that key compounds in Vernolac—including vernolactone, thymoquinone, and α-hederin—form novel interactions with cancer-related proteins such as β-catenin and CDK4, suggesting multiple mechanisms of potential anticancer activity.
The Quick Take
- What they studied: Whether a five-plant herbal supplement called Vernolac could slow the growth of cancer cells and how it might work in the body
- Who participated: This wasn’t a human study. Researchers used computer models to predict how the supplement works, then tested it on cancer cells grown in lab dishes to see if it actually slowed their growth
- Key finding: The supplement slowed the growth of several types of cancer cells in the lab, and it appeared to affect cancer cells much more than healthy cells, suggesting it might be selective in targeting cancer
- What it means for you: This is very early-stage research that shows promise but is nowhere near ready for people to use as a cancer treatment. Think of it as a first step in a very long journey. Anyone with cancer should continue working with their doctor on proven treatments
The Research Details
This study combined two different approaches. First, researchers used computer programs to analyze the five plants in Vernolac and predict which chemicals they contain and how those chemicals might interact with cancer-related proteins in the body. They identified 155 different plant chemicals that could potentially affect cancer. Second, they tested the actual supplement on cancer cells grown in laboratory dishes to see if it really did slow cell growth. This combination of computer prediction and lab testing helps researchers understand both how something might work and whether it actually does work.
Computer models help scientists narrow down which plant chemicals are worth studying further before spending time and money on expensive human trials. By combining computer predictions with actual lab tests, researchers can be more confident that their findings are real and not just theoretical. This approach is especially useful for studying traditional plant remedies that have been used for centuries but haven’t been scientifically validated
The study was published in a peer-reviewed scientific journal, which means other experts reviewed it before publication. However, this is early-stage research using only computer models and lab-grown cells, not human subjects. The results are promising but preliminary. The researchers were honest about limitations and called for more testing before any human use. No human trials have been conducted yet, so we don’t know if these lab results would translate to real benefits in people
What the Results Show
The Vernolac supplement contains at least 155 different plant chemicals that could potentially affect cancer. Computer analysis identified 14 key proteins that these chemicals might target, including proteins involved in cancer cell growth, cell death, and inflammation. When researchers tested the actual supplement on cancer cells in the lab, it successfully slowed the growth of four different types of cancer cells: breast cancer (MCF-7), colon cancer (Caco-2), and a type of brain cancer (NTERA-2). The supplement was particularly effective against the brain cancer cells. Importantly, the supplement had much less effect on healthy breast cells (MCF-10A), suggesting it might preferentially target cancer cells over normal cells.
The analysis revealed that the supplement may work through multiple different mechanisms simultaneously. Rather than attacking cancer in just one way, the plant chemicals appear to affect cancer cells through pathways related to cell death (apoptosis), immune system activation, reduction of harmful molecules (oxidative stress), and reduction of inflammation. The supplement also showed potential to affect how cancer cells resist drug treatments, which could make it useful alongside conventional cancer therapies. The most important plant chemicals identified were vernolactone, thymoquinone, quercetin, and carvacrol
Individual plants in this formula have been studied before, and previous research showed that extracts from each plant had some anticancer properties. This study is novel because it examines how all five plants work together as a combination. The finding that the combination affects multiple cancer pathways simultaneously is consistent with how traditional herbal medicine is thought to work—using multiple ingredients to address disease from different angles. This multi-target approach differs from many modern cancer drugs that focus on blocking a single protein
This research has important limitations. It was conducted entirely in computers and lab dishes—no human testing has been done. Lab results often don’t translate to real benefits in people because the human body is far more complex than a petri dish. The study didn’t test the supplement against standard cancer treatments to compare effectiveness. The exact doses used in lab tests may not match what people would take as a supplement. The supplement hasn’t been tested for safety in humans, and we don’t know what side effects it might cause. Finally, this is a single study, and results need to be confirmed by other independent research teams
The Bottom Line
Based on this research alone, Vernolac should NOT be used as a cancer treatment. This is preliminary laboratory research that shows potential but requires extensive additional testing. Anyone with cancer should continue working with their oncologist on proven, FDA-approved treatments. If someone is interested in complementary approaches alongside conventional treatment, they should discuss this with their doctor. Future clinical trials in humans would be needed before any recommendations could be made for patient use
Cancer researchers and pharmaceutical companies should care about this research because it identifies new potential drug targets and mechanisms. People interested in herbal medicine and natural compounds may find it interesting as an example of how traditional remedies are being studied scientifically. People with cancer should NOT use this as a basis for treatment decisions—this research is too preliminary. Healthcare providers should be aware of this research in case patients ask about it, so they can explain why it’s not yet appropriate for human use
This research is at the very beginning stage. If this supplement were to be developed into a cancer treatment, it would typically take 10-15 years of additional research, including animal studies, safety testing, and multiple phases of human clinical trials, before it could potentially be approved for medical use. Don’t expect any practical applications for many years
Frequently Asked Questions
Is Vernolac safe to use as a cancer treatment?
No. This research is preliminary laboratory work only. No human safety studies have been conducted. Anyone with cancer should use only proven, doctor-approved treatments. Always discuss any supplements with your oncologist before use
What plants are in Vernolac and why were they chosen?
Vernolac contains Vernonia zeylanica, Nigella sativa, Hemidesmus indicus, Leucas zeylanica, and Smilax glabra. These plants were chosen because previous research showed each individual plant had some anticancer properties. This study examined how they work together
How did researchers test if Vernolac works against cancer?
Researchers used two methods: computer programs to predict how plant chemicals interact with cancer proteins, and lab tests where they applied the supplement to cancer cells grown in dishes to measure growth reduction
When will Vernolac be available as a cancer treatment?
This research is too early to predict. Even if development continues, it typically takes 10-15 years of additional animal and human testing before a new treatment could be approved. No timeline can be established from this preliminary research
Can I use Vernolac alongside my regular cancer treatment?
Do not use any supplement without explicit approval from your oncologist. This research doesn’t support medical use yet. Your cancer doctor needs to know about everything you take to avoid dangerous interactions with proven treatments
Want to Apply This Research?
- Users interested in cancer prevention could track daily intake of the five plants in Vernolac (Vernonia zeylanica, Nigella sativa, Hemidesmus indicus, Leucas zeylanica, and Smilax glabra) through whole food sources like seeds, herbs, and roots, noting weekly consumption frequency
- Rather than using Vernolac as a supplement (which isn’t recommended based on this research), users could incorporate the individual plants into their diet through cooking with nigella seeds, using herbs in meals, or consuming foods containing these plant compounds, while maintaining regular cancer screening and preventive care
- Track overall dietary diversity and plant-based food consumption as a general wellness metric, while maintaining regular health checkups and cancer screenings as recommended by healthcare providers. Do not use app tracking as a substitute for medical care
This research is preliminary laboratory work that has not been tested in humans. Vernolac should not be used as a cancer treatment. Anyone with cancer must work with their oncologist on proven, FDA-approved treatments. This article is for educational purposes only and does not constitute medical advice. Do not use this information to make treatment decisions. Always consult with qualified healthcare providers before starting any supplement, especially if you have cancer or are undergoing cancer treatment. Some supplements can interfere with cancer medications or treatments. The findings described here may not apply to humans and require extensive additional research before any clinical use could be considered.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.